The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project
Briefly

"The AI supercomputer [will] ... provide an unprecedented potential to accelerate groundbreaking scientific discoveries in areas such as drug discovery, disease diagnosis and treatment," said Dr. Cédric Bourrasset.
The Novo Nordisk Foundation typically awards grants worth DKK 5 billion each year in various fields, including a recent increase to DKK 9.1 billion, with this project receiving an initial investment of DKK 600 million.
Read at Fortune Europe
[
add
]
[
|
|
]